4//SEC Filing
CUMBERLAND PHARMACEUTICALS INC 4
Accession 0001209191-17-026320
$CPIXCIK 0001087294operating
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 5:03 PM ET
Size
4.6 KB
Accession
0001209191-17-026320
Insider Transaction Report
Form 4
Griggs Jonathan
Director
Transactions
- Award
Common Stock
2017-04-07$6.45/sh+1,000$6,450→ 18,803 total
Footnotes (1)
- [F1]Restricted stock award will vest 100% on March 17, 2018.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeoperating
IncorporatedTN
Related Parties
1- filerCIK 0001087294
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 5:03 PM ET
- Size
- 4.6 KB